Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Forensic Sci Int ; 41(3): 255-60, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2777158

RESUMO

A 51-year-old male ingested orally a large quantity of toluene and died about 30 min later. The presence of toluene in body fluids and tissues was confirmed by gas chromatography and gas chromatography/mass spectrometry. Tissue distribution of toluene showed that the liver detected the highest content of toluene (433.5 micrograms/g), except for the stomach contents, followed by pancreas (88.2 micrograms/g), brain (85.3 micrograms/g), heart (62.6 micrograms/g), blood (27.6 micrograms/g), fat (12.2 micrograms/g) and finally cerebrospinal fluid (11.1 micrograms/g).


Assuntos
Tolueno/intoxicação , Cromatografia Gasosa , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Masculino , Pessoa de Meia-Idade , Suicídio , Tolueno/análise
2.
J Anal Toxicol ; 16(4): 214-6, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1501474

RESUMO

A rapid, simple method based on second-derivative spectroscopy of the simultaneous analysis of paraquat and diquat in serum and urine is described. Paraquat and diquat in serum were deproteinized with sulfosalicylic acid, and those in urine were reduced with NaOH-dithionite solution. A qualitative and quantitative analysis of reduced paraquat and diquat was made at the amplitude peaks of 396-403 nm and 454-464 nm in the second-derivative spectra, respectively. The entire procedure was completed within about 10 minutes for a serum sample and within about 5 minutes for a urine sample. Application of the proposed method on a poisoned patient is also reported.


Assuntos
Diquat/sangue , Diquat/urina , Paraquat/sangue , Paraquat/urina , Adulto , Cromatografia Líquida de Alta Pressão , Diquat/intoxicação , Feminino , Hemofiltração , Hemoperfusão , Humanos , Paraquat/intoxicação , Espectrofotometria Ultravioleta
3.
Afr J Med Med Sci ; 28(3-4): 159-61, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-11205822

RESUMO

The prevalence of gall stones in Africa is low even though this varies from one part of the continent to another. The few studies were hospital based and excluded majority of silent stones. Abdominal ultrasounds were carried out prospectively on 4,214 consecutive patients referred to an ultrasound centre which cares primarily for pregnant women--a well known vulnerable group for gall stones. An overall prevalence rate of 2.1% was found. This represents a 300-fold increase over previous figures in Ibadan albeit from a different study group. A further study of the disease in the general population is necessary, though it is suggested that the figure in the general population may be less. When this figure is compared with the 10 to 20% in Europe and North America, it confirms the low incidence of the disease in our environment. Majority of the stones were asymptomatic (95%). This needs to be confirmed in the general population. The average stone former in our environment as in previous study does not conform to the classical caucassian description.


Assuntos
Colelitíase/diagnóstico por imagem , Colelitíase/epidemiologia , Complicações na Gravidez/diagnóstico por imagem , Complicações na Gravidez/epidemiologia , Adolescente , Adulto , População Negra , Composição Corporal , Colelitíase/etiologia , Feminino , Humanos , Pessoa de Meia-Idade , Nigéria/epidemiologia , Paridade , Vigilância da População , Gravidez , Complicações na Gravidez/etiologia , Prevalência , Estudos Prospectivos , Encaminhamento e Consulta/estatística & dados numéricos , Fatores de Risco , Ultrassonografia Pré-Natal , Saúde da População Urbana/estatística & dados numéricos
4.
Nippon Ganka Gakkai Zasshi ; 100(9): 660-4, 1996 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-8905961

RESUMO

We developed a device to measure simultaneously the tension and elongation of the lens zonules, and the refractive power of the lens in 12 bovine eyes. Each sample, which consisted of the lens-zonuleciliary body was fixed to the device at the position of the ciliary process from four directions, and was stretched radially in a container filled with saline solution. The tension was measured by a force transducer, the elongation by a laser-displacement-meter, and the refractive power by a Campbell type refractometer. The refractive power of the lens in the relaxed condition was 24.6 +/- 3.4 D (n = 12, mean +/- standard deviation). When samples were stretched 1 mm from the relaxed condition, the increased change in tension was 2.8 +/- 1.5 g, and the decreased change in refractive power was 1.8 +/- 1.2 D.


Assuntos
Cristalino/fisiologia , Animais , Fenômenos Biomecânicos , Bovinos , Corpo Ciliar/fisiologia , Técnicas In Vitro , Refração Ocular
5.
Nihon Hoigaku Zasshi ; 47(1): 29-32, 1993 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-8315857

RESUMO

This report describes the postmortem diffusion of toluene in blood, brain, muscle and fat of rats exposed to toluene vapor. After exposure to toluene vapor (4,000 ppm) for 15 and 60 min, rats were killed by CO2 exposure and left for 12 and 24 hours in a fresh air. Toluene concentrations in blood, brain, muscle and fat were determined by head space gas chromatography. Postmortem decrease of toluene concentration in blood and increase of that in fat were observed with postmortem interval in both exposure conditions. But an extremely larger postmortem changes in the short exposure than those in the long exposure were observed. These are due to the facts that the value of fat/blood toluene concentration ratio at the time of death in the short exposure (3.3) was extremely smaller than that in the long exposure (10.5). Postmortem increase in muscle was also observed slightly. Postmortem concentrations in brain in both exposure intervals were relatively constant during these experiments. This postmortem stability is attributable to its anatomical features. These results suggest that brain toluene concentration at the autopsy is useful for the estimation of blood toluene concentration at the time of death and by comparison between toluene concentration in blood and that in brain it may be possible to presume the circumstances of death.


Assuntos
Tecido Adiposo/metabolismo , Encéfalo/metabolismo , Músculos/metabolismo , Mudanças Depois da Morte , Tolueno/farmacocinética , Animais , Difusão , Inalação , Masculino , Ratos , Ratos Wistar , Tolueno/sangue , Volatilização
11.
Biol Pharm Bull ; 17(3): 427-31, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7811321

RESUMO

Coated fine granules with water-insoluble film composed primarily of ethylcellulose, containing 20% of sparfloxacin (SPFX) and various amounts of low-substituted hydroxypropylcellulose (L-HPC) (0-52%) in the cores and which masked the bitter taste of SPFX, were orally administered to fasting rats to determine the effect of L-HPC on bioavailability. The release of SPFX in water from four kinds of these coated fine granules containing 0, 25, 40 and 52% of L-HPC showed the pseudo first order kinetics, followed by the second phase, with refractive points between 0.25 and 0.5 h. The rate constant (K1) up to 0.25 h increased with an increase [corrected] of the amount of L-HPC in the core, and the rate constant (K2) in subsequent release (the second phase) was lower than K1 in each fine granule. Areas under plasma concentration-time curves (AUC) of SPFX and the peak plasma SPFX levels (Cmax) after oral administration of coated fine granules lacking L-HPC to fasting rats were suppressed to one-eighth and one-ninth, respectively, of those obtained from the core granules that rapidly released SPFX. However, AUC and Cmax from the coated fine granules increased linearly with an increase in the amount of L-HPC in the cores, and nearly equaled those from the core fine granules when the content of L-HPC was 52%. These results confirmed that the addition of L-HPC to the cores increases not only the dissolution rate but also the bioavailability of SPFX.


Assuntos
Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/farmacocinética , Celulose/análogos & derivados , Fluoroquinolonas , Quinolonas/administração & dosagem , Quinolonas/farmacocinética , Paladar/efeitos dos fármacos , Animais , Anti-Infecciosos/efeitos adversos , Disponibilidade Biológica , Varredura Diferencial de Calorimetria , Celulose/química , Celulose/farmacologia , Excipientes , Injeções Intravenosas , Masculino , Pós , Quinolonas/efeitos adversos , Ratos , Ratos Wistar , Solubilidade
12.
Biol Pharm Bull ; 16(2): 172-7, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8395930

RESUMO

In order to prepare fine granules of sparfloxacin (SPFX), a new quinolone anti-bacterial drug that shows masking of the bitter taste of SPFX and dissolutes at a rapid rate, various film-coated fine granules containing 20% SPFX and 0-52% low-substituted hydroxypropylcellulose(L-HPC) in the cores, were prepared by a spray method. Mixtures of ethylcellulose (EC), hydroxypropylmethylcellulose (HPMC), titanium dioxide and sucrose stearate in weight ratios of X:Y:2:1 (X + Y = 6) were used as film materials. The degree of masking of the bitter taste by water-insoluble film, mainly consisting of EC and HPMC, increased by increasing the content ratio of EC to HPMC and the amount of films, but was also slightly affected by the amount of L-HPC in the cores, which were coated with either EC or EC/HPMC (4/2). On the other hand, the dissolution rate increased with an increased amount of L-HPC in the cores and with a decreasing ratio of EC to HPMC in the films. Increasing the amount of L-HPC in the cores, which induced a considerable expansion of the fine granules owing to their taking up of water from the dissolution medium, resulted in bursting of the film after a short lag time. The bioavailability of the film-coated fine granules containing 20% SPFX and 52% L-HPC in the cores and 10% EC/HPMC (4/2) in the coating film, which masked the bitter taste of SPFX and showed the optimal release characteristics, was equivalent to that of conventional tablets containing 100 mg SPFX in beagle dogs.


Assuntos
Anti-Infecciosos/administração & dosagem , Fluoroquinolonas , Quinolonas/administração & dosagem , Paladar , Animais , Anti-Infecciosos/farmacocinética , Anti-Infecciosos/farmacologia , Disponibilidade Biológica , Cápsulas , Fenômenos Químicos , Química Farmacêutica , Físico-Química , Cães , Excipientes , Humanos , Masculino , Tamanho da Partícula , Quinolonas/farmacocinética , Quinolonas/farmacologia , Solubilidade , Comprimidos
13.
Phys Rev D Part Fields ; 42(10): 3461-3468, 1990 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-10012748
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA